<<Concerning the above past financing, as I have said before, it is the only thing I have heard negative about this stock.>>
Oh really? What's your take on the fact that Raymond James gets a cut of "research" money? What about the shady dealings with Blech, etc, etc. etc.?
<<There have been several in depth research reports done on TXB, and it is consistently rated a strong buy.>>
Rated a strong buy by analysts who have a direct financial interest in the company (i.e. handling the public offfering, etc.). I'll trust my own research...thanks.
<<Concerning their products, who cares if they were developed in house or not?>>
When the company obfuscates the fact that these are licensed or generic drugs and instead implies that they were developed in-house, then I would question the integrity of management.
<<TXB has been for awhile, and continues to be, one of the top speculative Biotechs.>>
LOL!!!!!!!!!!!! Yeah, and Vegas continues to be one of the top sucker draws. TXB has never produced anything except more worthless stock. The track record speaks for itself. Enough said.
<< If is is approved by the FDA first quarter 1998, like predicted, it will cause the stock to at least double, IMO. >>
Novastan will not be approved by the FDA because the HIT clinical trails were fudged from the outset. |
